Comparison of different strategies for acute ST-segment elevation myocardial infarction with high thrombus burden in clinical practice: Symptom-free outcome at one year

Heart and Lung

Volumn 44, Issue 6, 2015, Pages 487-493

  Lee, Wei Chieh ^a   Chen, Huang Chung ^a   Fang, Hsiu Yu ^a   Hsueh, Shu Kai ^a   Chen, Chien Jen ^a   Yang, Cheng Hsu ^a   Yip, Hon Kan ^a   Wu, Chiung Jen ^a   Fang, Chih Yuan ^a   Hang, Chi Ling ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Distal protection device; GP IIb IIIa receptor inhibitor; High thrombus burden plaque; Primary percutaneous coronary intervention; ST elevation myocardial infarction; Symptom free outcomes

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; TIROFIBAN; TYROSINE;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL EMBOLISM; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBUS; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; COMPLICATION; CORONARY THROMBOSIS; DOSE RESPONSE; ELECTROCARDIOGRAPHY; INTRAARTERIAL DRUG ADMINISTRATION; MIDDLE AGED; MYOCARDIAL INFARCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY THROMBOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TYROSINE;

EID: 84946909924     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2015.08.003     Document Type: Article

References (27)

1. Chen J., Hsieh A.F., Dharmarajan K., Masoudi F.A., Krumholz H.M. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation 2013, 128:2577-2584.
2. Steg P.Gabriel, James Stefan K., Atar Dan, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
3. O'Gara Patrick T., Kushner Frederick G., Ascheim Deborah D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013, 127:e362-425.
4. Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 2005, 100:179-190.
5. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation 1989, 80:1049-1062.
6. Morishima I., Sone T., Okumura K., et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term out-come in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000, 36:1202-1209.
7. Resnic F.S., Wainstein M., Lee M.K., et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 2003, 145:42-46.
8. Vlaar P.J., Svilaas T., van der Horst I.C., et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS): a 1-year follow-up study. Lancet 2008, 371:1915-1920.
9. Fröbert O., Lagerqvist B., Olivecrona G.K., et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 2013, 369:1587-1597.
10. Lagerqvist B., Fröbert Ole, Olivecrona Göran K., et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 2014, 371:1111-1120.
11. Stone Gregg W. Simple aspiration in acute myocardial infarction: too simple to be true?. Eur Heart J 2012, 33:3005-3007.
12. Onuma Y., Thuesen L., van Geuns R.J., et al. Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study-TROFI trial. Eur Heart J 2013, 34:1050-1060.
13. Baim D.S., Wahr D., George B., et al. Randomized trial of a distal embolic Protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002, 105:1285-1290.
14. Huang Z., Katoh O., Nakamura S., Negoro S., Kobayashi T., Tanigawa J. Evaluation of the PercuSurge GuardWire plus temporary occlusion and aspiration system during primary angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv 2003, 60:443-451.
15. Kusuyama T., Kataoka T., Iida H., et al. Comparison of Temporary occlusion and aspiration system versus the conventional Method during coronary stenting for acute myocardial infarction. Am J Cardiol 2004, 94:1041-1043.
16. Kelbaek H., Terkelsen C.J., Helqvist S., et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol 2008, 51:899-905.
17. Ochała A., Smolka G., Wojakowski W., Gabrylewicz B., Garbocz P., Tendera M. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty. Kardiol Pol 2007, 65:672-680.
18. Tcheng J.E., Kandzari D.E., Grines C.L., et al. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction. Circulation 2003, 108:1316-1323.
19. Ten Berg J.M., van 't Hof A.W., Dill T., et al. Pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial Infarcon on short- and long-term clinical outcome. J Am Coll Cardiol 2010, 55:2446-2455.
20. Mehilli J., Kastrati A., Schulz S., et al. Abciximab in patients with acute ST-Segment-Elevation myocardial infarction undergoing primary percutaneous coronary intervention after Clopidogrel Loading. Circulation 2009, 119:1933-1940.
21. De Luca Giuseppe, Navarese Eliano Pio, Suryapranata Harry A meta-analytic overview of thrombectomy during primary angioplasty. Int J Cardiol 2013, 166:606-612.
22. Burzotta Francesco, De Vita Maria, Gu Youlan L., et al. Clinical impact of thrombectomy in acute ST- elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J 2009, 30:2193-2203.
23. Mongeon F.P., Bélisle P., Joseph L., Eisenberg M.J., Rinfret S. Adjunctive thrombectomy for acute myocardial infarction: a bayesian meta-analysis. Circ Cardiovasc Interv 2010, 3:6-16.
24. Stone G.W., Maehara A., Witzenbichler B., et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 2012, 307:1817-1826.
25. Valgimigli Marco, Biondi-Zoccai Giuseppe, Tebaldi Matteo, et al. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J 2012, 31:35-49.
26. Brand F.N., Larson M., Friedman L.M., Kannel W.B., Castelli W.P. Epidemiologic assessment of angina before and after myocardial infarction: the Framingham study. Am Heart J 1996, 132:174-178.
27. Pocock S.J., Henderson R.A., Clayton T., Lyman G.H., Chamberlain D.A. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. J Am Coll Cardiol 2000, 35:907-914.